Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53 mutations in bladder carcinoma cell lines

M J Cooper1, J J Haluschak, D Johnson

  • 1Department of Medicine, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, OH 44106-4937, USA.

Oncology Research
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of serum acetylsalicylic acid in a porcine model of aspirin overdose.

Veterinary and human toxicology·1996
Same author

Augmentation of hypoxic pulmonary vasoconstriction by N(G)-L-methyl-arginine in a rabbit model of thermal injury.

The American journal of emergency medicine·1996
Same author

Counseling to reduce road injuries and deaths.

Canadian family physician Medecin de famille canadien·1996
Same author

Pacemaker patient-triggered event recording: accuracy, utility, and cost for the pacemaker follow-up clinic.

Pacing and clinical electrophysiology : PACE·1996
Same author

Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44.

The Journal of clinical investigation·1996
Same author

Unusual features of osteoarticular tuberculosis in children.

The Journal of pediatrics·1996
Same journal

New Paradigm in Ocular Surface Squamous Neoplasia-Insights from a Case Report on the Use of Interferon in Treatment.

Oncology research·2026
Same journal

Clinical Application Progress of Artificial Intelligence in Pancreatic Cancer: From Diagnosis to Immunotherapy.

Oncology research·2026
Same journal

Exploring the Role of CD44 in the Progression and Invasion of Chondrosarcoma.

Oncology research·2026
Same journal

Retraction: Long Noncoding RNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation and Invasion in Gastric Cancer via Negatively Modulating miRNA-145-5p.

Oncology research·2026
Same journal

Retraction: Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.

Oncology research·2026
Same journal

Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer.

Oncology research·2026
See all related articles

Point mutations in the p53 tumor suppressor gene are common in bladder cancer. This study analyzes p53 mutations in bladder cancer cell lines, providing a model for future research.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Point mutations and deletions in the p53 tumor suppressor gene are frequently observed in advanced bladder tumors.
  • Understanding p53 alterations in vitro is crucial for modeling bladder tumorigenicity.

Purpose of the Study:

  • To investigate the presence and characteristics of p53 mutations in a panel of bladder carcinoma cell lines.
  • To establish an in vitro model for studying the role of p53 in bladder cancer development.

Main Methods:

  • Cloning of p53 alleles using reverse transcriptase-polymerase chain reaction (RT-PCR).
  • Sequencing of p53 exons 2-11.
  • Western blot analysis for p53 protein expression.
  • Analysis of p53 binding to SV40 large T antigen.

Related Experiment Videos

Main Results:

  • Five of 11 cell lines exhibited missense point mutations in p53, often in conserved 'hot spot' domains, and overexpressed p53 protein.
  • One cell line (HT-1197) showed an unusual C-terminal mutation affecting the tetramerization domain.
  • Six cell lines had wild-type p53 expression; four had deletions/truncations, and two had wild-type p53.
  • A novel p53 mutant with a tyrosine 126 deletion was identified in the T24 cell line, exhibiting impaired SV40 large T antigen binding.

Conclusions:

  • p53 mutations are diverse in bladder carcinoma cell lines, including missense mutations, deletions, and truncations.
  • Specific mutations may correlate with altered protein conformation, oligomerization, and function.
  • This panel of cell lines serves as a valuable model for exploring the functional consequences of wild-type and mutant p53 in bladder tumorigenesis.